We’re honored to participate in the Morgan Stanley Healthcare Conference in New York City from September 4 – 6. We extend our gratitude to the organizers for hosting this event. Shehnaaz Suliman, our CEO, and Erica Jefferson, SVP, Corporate Affairs, will be in attendance. We look forward to engaging discussions and collaborations that shape the future of biotechnology. See you in New York City!

We’re gearing up to attend the RNA Leaders USA Congress from September 4 – 5 in San Diego, CA. This conference is an essential gathering for professionals dedicated to the future of mRNA therapies. We look forward to speaking on our advancements and learning from the wealth of knowledge presented by experts in the field.

We look forward to attending the 47th European Cystic Fibrosis Conference in Glasgow from June 5 – 8. We welcome this opportunity to discuss RCT2100, our clinical-stage candidate in development to treat the 10-13% of CF patients who have Class I mutations in the CFTR gene and do not respond to currently approved CFTR modulators.